Qtron Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Buy
2,839
+664
+31% +$175K 0.11% 229
2026
Q1
$580K Buy
2,175
+2
+0.1% +$542 0.08% 307
2025
Q4
$545K Buy
+2,173
New +$577K 0.07% 306
2022
Q4
– Sell
-3,019
Closed -$531K – 440
2022
Q3
$531K Sell
3,019
-946
-24% -$194K 0.13% 217
2022
Q2
$798K Hold
3,965
– – 0.18% 159
2022
Q1
$898K Hold
3,965
– – 0.2% 138
2021
Q4
$1.07M Hold
3,965
– – 0.24% 114
2021
Q3
$959K Buy
+3,965
New +$999K 0.26% 109

Other funds holding LH

Qtron Investments's LH Position: Q2 2026 in Review

Qtron Investments increased its Labcorp (LH) stake by 31% in Q2 2026, buying an estimated $175K and bringing the position to 2,839 shares worth $795K. The position accounts for 0.11% of the portfolio, ranked #229.

Qtron Investments first reported a position in LH in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.07M in Q4 2021. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Qtron Investments held 2,839 shares of Labcorp worth $795K as of Q2 2026.
  • Qtron Investments bought 664 Labcorp shares in Q2 2026, an estimated $175K.
  • Labcorp made up 0.11% of Qtron Investments's portfolio in Q2 2026, its #229 holding.
  • Qtron Investments first reported a position in Labcorp in Q3 2021 and has held it in 8 quarters since.
  • Qtron Investments's Labcorp position peaked at $1.07M in Q4 2021.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.